A prospective randomized trial comparing stenting with off-pump coronary surgery for high-grade stenosis in the proximal left anterior descending coronary artery: Three-year follow-up

被引:57
作者
Drenth, DJ
Veeger, NJGM
Winter, JB
Grandjean, JG
Mariani, MA
van Boven, AJ
Boonstra, PW
机构
[1] Univ Groningen Hosp, Dept Cardiothorac Surg, Thoraxctr, NL-9700 RB Groningen, Netherlands
[2] Pisa Univ Hosp, Thoraxctr, Pisa, Italy
关键词
D O I
10.1016/S0735-1097(02)02536-6
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study was done to identify the best treatment for an isolated high-grade stenosis of the proximal left anterior descending coronary artery (LAD). BACKGROUND Percutaneous transluminal coronary angioplasty with stenting (PCI) and of-pump coronary artery bypass grafting (surgery) are used to treat single-vessel disease of a high-grade stenosis of the proximal LAD. Midterm results of both treatments are compared in this prospective randomized study. METHODS In a single-center prospective trial, we randomly assigned 102 patients with a high-grade stenosis of the proximal LAD (American College of Cardiology/American Heart Association classification type B2 or C) to PCI (n = 51) or surgery (n = 51). Primary composite end point was freedom from Major Adverse Cardiac and Cerebrovascular Events (MACCE) at follow-up, including death, myocardial infarction, cerebrovascular accident, and repeat target vessel revascularization (TVR). Secondary end points were angina pectoris class and need for antianginal medication at follow-up. Analysis was by intention-to-treat (ITT) and received treatment (RT). RESULTS Mean follow-up time was three years (90% midrange, two to four years). Incidence of MACCE was 23.5% after PCI and 9.8% after surgery; p = 0.07 ITT (24.1% vs. 8.3%; p = 0.04 RT). After surgery a significantly lower angina pectoris class (p = 0.02) and need for antianginal medication (p = 0.01) was found compared to PCI. Target vessel revascularization was 15.7% after PCI and 4.1% after surgery (p = 0.09). CONCLUSIONS At three-year follow-up (range, two to four years), a trend in favor of surgery is observed in regard to MACCE-free survival with a significantly lower angina pectoris status and significantly lower need for antianginal medication. (C) 2002 by the American College of Cardiology Foundation.
引用
收藏
页码:1955 / 1960
页数:6
相关论文
共 16 条
[1]  
Boonstra PW, 1997, ANN THORAC SURG, V63, P567
[2]   Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions [J].
Cura, FA ;
Bhatt, DL ;
Lincoff, AM ;
Kapadia, SR ;
L'Allier, PL ;
Ziada, KM ;
Wolski, KE ;
Moliterno, DJ ;
Brener, SJ ;
Ellis, SG ;
Topol, EJ .
CIRCULATION, 2000, 102 (01) :28-34
[3]   Quality assessment in minimally invasive coronary artery bypass grafting [J].
Diegeler, A ;
Matin, M ;
Falk, V ;
Binner, C ;
Walther, T ;
Autschbach, R ;
Mohr, FW .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1999, 16 :S67-S72
[4]   Minimally invasive coronary artery bypass grafting versus percutaneous transluminal coronary angioplasty with stenting in isolated high-grade stenosis of the proximal left anterior descending coronary artery: Six months' angiographic and clinical follow-up of a prospective randomized study [J].
Drenth, DJ ;
Winter, JB ;
Veeger, NJGM ;
Monnink, SHJ ;
van Boven, AJ ;
Grandjean, JG ;
Mariani, MA ;
Boonstra, PW .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2002, 124 (01) :130-135
[5]   A prospective randomized trial comparing stenting to internal mammary artery grafting for proximal, isolated de novo left anterior coronary artery stenosis: The SIMA trial [J].
Goy, JJ ;
Kaufmann, U ;
Goy-Eggenberger, D ;
Garachemani, A ;
Hurni, M ;
Carrel, T ;
Gaspardone, A ;
Burnand, B ;
Meier, B ;
Versaci, F ;
Tomai, F ;
Bertel, O ;
Pieper, M ;
de Benedictis, M ;
Eeckhout, E .
MAYO CLINIC PROCEEDINGS, 2000, 75 (11) :1116-1123
[6]   Coronary artery bypass grafting without cardiopulmonary bypass using the octopus method:: Results in the first one hundred patients [J].
Jansen, EWL ;
Borst, C ;
Lahpor, JR ;
Gründeman, PF ;
Eefting, FD ;
Nierich, A ;
de Medina, EOR ;
Bredée, JJ .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1998, 116 (01) :60-67
[7]   Restenosis after coronary placement of various stent types [J].
Kastrati, A ;
Mehilli, J ;
Dirschinger, J ;
Pache, J ;
Ulm, K ;
Schühlen, H ;
Seyfarth, M ;
Schmitt, C ;
Blasini, R ;
Neumann, FJ ;
Schömig, A .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (01) :34-39
[8]   Coronary in-stent restenosis: Current status and future strategies [J].
Lowe, HC ;
Oesterle, SN ;
Khachigian, LM .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (02) :183-193
[9]   A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. [J].
Morice, M ;
Serruys, PW ;
Sousa, JE ;
Fajadet, J ;
Hayashi, EB ;
Perin, M ;
Colombo, A ;
Schuler, G ;
Barragan, P ;
Guagliumi, G ;
Molnar, F ;
Falotico, R .
NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (23) :1773-1780
[10]  
O'Keefe JH, 1999, CIRCULATION, V100, P114